Insulin Resistance Indexes as Biomarkers of Lifetime Cardiovascular Risk among Adults from Peru

Table 3

Prevalence ratio and 95% CIs for lifetime cardiovascular risk according to levels of insulin resistance indexes.

Markers	Overall	Men	Women
	PR (95% CI)	PR (95% CI)	PR (95% CI)
TG/HDL-C
Model 1^a	1.26 (1.17–1.40)	1.23 (1.08–1.40)	1.26 (1.10–1.44)
Model 2^b	1.15 (1.04–1.28)	1.22 (1.05–1.42)	1.16 (1.04–1.36)
TyG
Model 1^a	3.00 (2.16–4.16)	1.99 (1.28–3.08)	4.08 (2.35–7.10)
Model 2^b	2.47 (1.44–4.23)	1.98 (1.01–3.87)	3.25 (1.39–7.60)

PR, prevalence ratio; 95% CI, 95% confidence interval; TG/HDL-C, triglycerides to HDL-cholesterol ratio; TyG, triglyceride glucose index. ^aNonadjusted and ^badjusted for HbA1c, LDL-C, uric acid, and alcohol consumption; ; .